S.No. |
Chemical Name of the Intermediate |
CAS No. |
Related to API |
Therapeutic category |
1 |
5-bromo-2-chloro-4'-ethoxydiphenylmethane |
461432-23-5 |
Dapagliflozin |
Anti Diabetic |
2 |
5-bromo-2-chlorophenyl)(4-ethoxyphenyl) methanone |
461432-22-4 |
3 |
2,3,4,6-Tetrakis-O-trimethylsilyl-Dgluconolactone |
32384-65-9 |
4 |
Methyl 1-C- [4-chloro-3- [(4-ethoxyphenyl) methyl] phenyl]-alpha-D-gluco pyranoside |
714269-57-5 |
5 |
(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4ethoxyphenyl)methyl]phenyl]-D-glucitol tetra acetate |
461432-25-7 |
6 |
3-(3-Chloropropyl)-1,3-dihydro-7, 8-dimethoxy-
2H-3-benzazepin-2-one |
85175-59-3 |
Ivabradine HCl |
Cardio vascular |
7 |
1,3-Dihydro-3- (3-iodopropyl)-7,8-dimethoxy-
2H-3-benzazepin-2-one |
148870-57-9 |
8 |
[(S)-3-(3-(((3,4-dimethoxy bicyclo [4.2.0] octa-1 (6), 2,4-trien-7-yl) methyl) (methyl) amino) propyl)-7,8-dimethoxy-1, 3-dihydro-2H-benzo[d] `azepin-2-one] |
1086026-31-4 |
9 |
4-(4-chlorophenyl)-1H-benzo[d][1,2] oxazin-1one |
2224-83-1 |
Chlorthalidone |
Cardio vascular |
10 |
3-(4-chlorophenyl) isoindolin-1-one |
2224-77-3 |
11 |
2-Chloro-5- (2,3-dihydro-3-oxo-1H-isoindol-1yl)-benzene sulfonamide |
82875-49-8 |
12 |
2-Chloro-3, 4-dihydroxyacetophenone |
99-40-1 |
Isoproterenol HCl |
Cardio vascular |
13 |
1-(3,4-dihydroxyphenyl)-2-(isopropyl amino) ethan-1-one Hydrochloride |
16899-81-3 |
14 |
(3R, 4S, 5R)-2-(6-amino-2-chloro-9H-purin-9yl)-5-(hydroxymethyl) tetrahydrofuran-3, 4-diol |
146-77-0 |
Regadenoson |
Contrast Agent |
15 |
(3R, 4S, 5R)-2-(6-amino-2-hydrazinyl-9H-purin-9-yl)-5-(hydroxymethyl) tetrahydrofuran-3,4-diol |
15763-11-8 |
16 |
Ethyl1- (6-amino-9- ((3R, 4S, 5R)-3,4dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2yl)-9H-purin-2-yl)-1H-pyrazole-4-carboxylate |
313348-29-7 |
17 |
1-(6-amino-9- ((3R, 4S, 5R)-3,4-dihydroxy-5 (hydroxymethyl) tetrahydrofuran-2-yl)-9H-purin2-yl)-1H-pyrazole-4-carboxylic acid |
313348-16-2 |
18 |
Phenyl Hydrazine Hydrochloride |
59-88-1 |
Edaravone |
To treat Amyotrophic Lateral Sclerosis |
19 |
1-(7,8-diamino-1, 2,4,5-tetrahydro-3H-1, 5methanobenzo [d] azepin-3-yl)-2,2,2trifluoroethan-1-one |
230615-69-7 |
Varenicline Tartrate |
Smoking cessation |
20 |
2,2,2-trifluoro-1- (6,7,9,10-tetrahydro-8H-6, 10methanoazepino [4,5-g] quinoxalin-8-yl) ethan-1-one |
230615-70-0 |
21 |
Varenicline Free Base |
249296-44-4 |
22 |
N,N-dimethyl-4-nitrosoaniline Hydrochloride |
42344-05-8 |
Methylene Blue |
To treat methemoglobinemia |
23 |
N1,N1-dimethylbenzene-1,4-diamine (DMPPDA) |
99-98-9 |
24 |
2-Amino-5-dimethylaminophenyl Thiosulphonic acid |
43035-11-6 |
25 |
2-(3,4-dimethylphenyl)-5-methyl-1, 2-dihydro-3H-pyrazol-3-one |
277299-70-4 |
Eltrombopag |
Medication for conditions that lead to thrombocytopenia |
26 |
Eltrombopag Free Acid |
496775-61-2 |
27 |
(2R, 3R)-3-(2,3-dihydrobenzo [b][1,4] dioxin-6yl)-3-hydroxy-2-(((S)-2-hydroxy-1-phenylethyl) amino)-1-(pyrrolidin-1-yl)propan-1-one |
491833-26-2 |
Eliglustat Tartrate |
Gaucher Disease type-1 |
28 |
(1R, 2S)-1-(2,3-dihydrobenzo [b][1,4] dioxin-6yl)-2-(((S)-2-hydroxy-1-phenylethyl) amino)-3(pyrrolidin-1-yl) propan-1-ol |
491833-27-3 |
29 |
(1R, 2S)-2-amino-1- (2, 3-dihydrobenzo [b][1,4] dioxin-6-yl)-3-(pyrrolidin-1-yl) propan-1-ol |
491833-28-4 |
30 |
Eliglustat Free Base |
491833-29-5 |
31 |
(2S)-1-[[(2-Amino-1,1-dimethylethyl)amino]acetyl]-2-pyrrolidinecarbonitrile |
794460-89-2 |
Anagliptin |
Antidiabetic |
32 |
2-Methyl-pyrazolo[1,5-a]pyrimidine-6-carboxylic acid |
739364-95-5 |
33 |
6-amino-1,3-dimethylpyrimidine-2,4(1H,3H)-dione |
6642-31-5 |
Theophylline |
COPD & Asthma |
34 |
6-amino-1,3-dimethyl-5-nitrosopyrimidine-2,4(1H,3H)-dione |
6632-68-4 |
35 |
5,6-diamino-1,3-dimethylpyrimidine-2,4(1H,3H)-dione |
5440-00-6 |
36 |
N-(5-amino-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)formamide |
7597-60-6 |
37 |
3-(4-chlorophenyl) propanoic acid |
2019-34-3 |
Pitolisant HCl |
Narcolepsy with or without cataplexy |
38 |
3-(4-chlorophenyl) propan-1-ol |
6282-88-8 |
39 |
3-(4-chlorophenyl) propyl methane sulfonate |
61440-60-6 |
40 |
3-(piperidin-1-yl) propan-1-ol |
104-58-5 |
41 |
Sodium 3-(piperidin-1-yl) propan-1-olate |
462115-38-4 |
42 |
6-amino-1, 3-diethylpyrimidine-2, 4(1H, 3H)dione |
41740-15-2 |
Istradefylline |
Parkinson's disease |
43 |
6-amino-1, 3-diethyl-5-nitrosopyrimidine-2,4(1H, 3H)-dione |
89073-60-9 |
44 |
5,6-diamino-1, 3-diethylpyrimidine-2, 4(1H,3H)-dione |
1785764-26-2 |
45 |
(E)-3-(3,4-dimethoxyphenyl) acrylic acid |
14737-89-4 |
46 |
(E)-N- (6-amino-1, 3-diethyl-2, 4-dioxo-1, 2,3,4tetrahydropyrimidin-5-yl)-3-(3,4dimethoxyphenyl) acrylamide |
187393-68-6 |
47 |
(E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-3, 7dihydro-1H-purine-2, 6-dione |
155270-98-7 |
48 |
ethyl 7-bromo-2,2-dimethylheptanoate |
123469-92-1 |
Bempedoic acid |
Hypercholesterolemia |
49 |
diethyl 8-cyano-2,2,14,14-tetramethyl-8-tosylpentadecanedioate |
738606-44-5 |
50 |
diethyl 2,2,14,14-tetramethyl-8-oxopentadecanedioate |
738606-43-4 |
51 |
2,2,14,14-tetramethyl-8-oxopentadecanedioic acid |
413624-71-2 |
52 |
2-(benzyl(methyl)amino)acetaldehyde |
166947-11-1 |
Revefenacin |
Chronic obstructive pulmonary disease (COPD) |
53 |
1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
743460-48-2 |
54 |
piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
171722-92-2 |